Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study.
Mohammed Imran, Kulkarni Bina, Faraj Lana A, Abbas Ali, Dua Harminder S, King Anthony J
This 2-year study found BAK-preserved glaucoma drops cause sustained ocular surface inflammation and symptoms, unlike preservative-free or polyquad drops. Clinically, this highlights BAK's detrimental effects.